Sign in
Taking people in NetherlandsPhase 1

Scan test for fibrosis in colorectal cancer that has spread to the abdomen

Tests a FAPI-PET scan to detect scarring in abdominal spread of colorectal cancer.

Key facts

Who runs it
Universitair Medisch Centrum Utrecht
Where
Amsterdam, NetherlandsSee the site
Registry title
The detection of tumor-associated fibrosis in colorectal peritoneal metastases by FAPI-PET (TROMPET)
Status
Recruiting
Phase
Phase 1
People taking part
25 people, planned
Started
12 Dec 2024
Expected to end
31 May 2027
Type of study
Interventional
Record updated
3 March 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with metastatic colorectal cancer. It studies FAPI-PET to detect tumor-associated fibrosis in colorectal peritoneal metastases.

Age
18 years or older
Sex
All sexes can join.
Disease stage
Metastatic colorectal cancer

Where in Netherlands

  • Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis StichtingAmsterdam, NetherlandsTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Plain-language title
Scan test for fibrosis in colorectal cancer that has spread to the abdomenGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Record updated
3 March 2026